Redhill Biopharma (RDHL) Stock Price
Redhill Biopharma Price
Over the last 14 years Redhill Biopharma grew revenue by 19.7% annually, reaching 286,000.00 USD. For Redhill Biopharma, the net margin of -150.0% is down versus -114.0% a few years ago.
Redhill Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Redhill Biopharma business model & stock analysis
Frequently asked questions about Redhill Biopharma
7 analysts currently rate the Redhill Biopharma stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Redhill Biopharma share trades at 0.40 EUR (0.45 USD).
The revenue cannot currently be calculated for Redhill Biopharma.
The profit cannot currently be calculated for Redhill Biopharma.
The P/E ratio cannot be calculated for Redhill Biopharma at the moment.
The P/S cannot be calculated for Redhill Biopharma currently.
The Eulerpool Quality Score for Redhill Biopharma is 2/10.
The ISIN of Redhill Biopharma is US7574681034. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Redhill Biopharma is RDHL. The ticker symbol is used to trade Redhill Biopharma shares on the stock exchange.
Redhill Biopharma stock
Redhill Biopharma Peer Group
All fundamentals and in-depth analysis of Redhill Biopharma
Our stock analysis for Redhill Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Redhill Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.